• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Public Health . Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era

tetano

Editor, Senior Moderator
J Infect Public Health


. 2024 Oct 28;17(12):102570.
doi: 10.1016/j.jiph.2024.102570. Online ahead of print. Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era

Takahiro Mori[SUP] 1 [/SUP], Taito Kitano[SUP] 2 [/SUP], Daisuke Kitagawa[SUP] 3 [/SUP], Masayuki Murata[SUP] 1 [/SUP], Mai Onishi[SUP] 1 [/SUP], Soshi Hachisuka[SUP] 1 [/SUP], Tenshin Okubo[SUP] 1 [/SUP], Naohiro Yamamoto[SUP] 1 [/SUP], Hiroki Nishikawa[SUP] 1 [/SUP], Masayuki Onaka[SUP] 1 [/SUP], Rika Suzuki[SUP] 1 [/SUP], Madoka Sekine[SUP] 3 [/SUP], Soma Suzuki[SUP] 3 [/SUP], Fumihiko Nakamura[SUP] 3 [/SUP], Sayaka Yoshida[SUP] 1 [/SUP]



Affiliations
Abstract

Background: To evaluate the effect of the type and codetection of respiratory viruses on admission requirements among children with respiratory infections in the post-COVID-19 pandemic era.
Methods: In this retrospective study, we analyzed patients with acute respiratory symptoms using FilmArray® Respiratory Panel between December 2020 and March 2024. The viruses were classified into eight groups: adenovirus, seasonal coronavirus, human metapneumovirus, human rhinovirus/enterovirus, influenza virus, parainfluenza virus, respiratory syncytial virus, and severe acute respiratory virus coronavirus-2. The impact of the detected viral groups and viral codetection on hospitalization rates were examined using multivariable regression analysis in three pediatric age groups (<2 years, 2-4 years, and 5-17 years).
Results: A total of 4684 tests were performed, of which 3555 (75.9 %) tested positive for at least one respiratory virus and negative for atypical bacteria. Of these, 946 (26.6 %) were hospitalized. Multivariable regression analyses showed that respiratory syncytial virus (RSV) infection was associated with hospitalization requirement among young children (adjusted odds ratios (aOR) 2.46 [1.65-3.67], p < 0.001 in < 2 years, and 1.34 [1.02-2.30], p = 0.042 in 2-4 years). Influenza (aOR 0.23 [0.07-0.83], p = 0.025) and SARS-CoV-2 (aOR 0.39 [0.22-0.69], p = 0.001) were negatively correlated with hospitalization among children younger than 2 years. Viral codetection was not significantly associated with hospitalization in any pediatric age group.
Conclusion: RSV infection was associated with a higher risk of hospitalization in children younger than 5 years than other respiratory viruses. These results highlight the importance of preventive measures against RSV infections, including maternal vaccination and childhood immunization.

Keywords: Children; Influenza; Respiratory syncytial virus; Respiratory tract infections; SARS-CoV-2.

 
Back
Top Bottom